Alfons Segarra-Medrano

568 total citations
12 papers, 166 citations indexed

About

Alfons Segarra-Medrano is a scholar working on Nephrology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Alfons Segarra-Medrano has authored 12 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 5 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Alfons Segarra-Medrano's work include Renal Diseases and Glomerulopathies (7 papers), Autoimmune Bullous Skin Diseases (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Alfons Segarra-Medrano is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Autoimmune Bullous Skin Diseases (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Alfons Segarra-Medrano collaborates with scholars based in Spain and Palestinian Territory. Alfons Segarra-Medrano's co-authors include Irene Agraz, Natàlia Ramos, Fernando Martínez‐Valle, Roser Soláns-Laqué, Miquel Vilardell‐Tarrés, M.T. Allende, Eva Balada, Josep Ordi‐Ros, Moisés Labrador‐Horrillo and Luis Martínez‐Lostao and has published in prestigious journals such as PLoS ONE, Lupus and The Journal of Rheumatology.

In The Last Decade

Alfons Segarra-Medrano

12 papers receiving 165 citations

Peers

Alfons Segarra-Medrano
Alfons Segarra-Medrano
Citations per year, relative to Alfons Segarra-Medrano Alfons Segarra-Medrano (= 1×) peers Veronika Satrapová

Countries citing papers authored by Alfons Segarra-Medrano

Since Specialization
Citations

This map shows the geographic impact of Alfons Segarra-Medrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfons Segarra-Medrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfons Segarra-Medrano more than expected).

Fields of papers citing papers by Alfons Segarra-Medrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfons Segarra-Medrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfons Segarra-Medrano. The network helps show where Alfons Segarra-Medrano may publish in the future.

Co-authorship network of co-authors of Alfons Segarra-Medrano

This figure shows the co-authorship network connecting the top 25 collaborators of Alfons Segarra-Medrano. A scholar is included among the top collaborators of Alfons Segarra-Medrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfons Segarra-Medrano. Alfons Segarra-Medrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Martín, Marisa, et al.. (2021). Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy. Clinical Kidney Journal. 14(12). 2556–2562. 10 indexed citations
2.
Segarra-Medrano, Alfons, et al.. (2019). Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome. The Journal of Rheumatology. 47(3). 407–414. 31 indexed citations
3.
Segarra-Medrano, Alfons, et al.. (2019). Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 13(4). 607–612. 10 indexed citations
4.
Segarra-Medrano, Alfons, et al.. (2019). Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism. Kidney Research and Clinical Practice. 38(2). 229–238. 8 indexed citations
6.
Segarra-Medrano, Alfons, et al.. (2017). Estudio de las variables asociadas a la activación local del complemento en la nefropatía IgA idiopática. Nefrología. 37(3). 320–329. 13 indexed citations
7.
Segarra-Medrano, Alfons, et al.. (2017). Study of the variables associated with local complement activation in IgA nephropathy. Nefrología (English Edition). 37(3). 320–329. 10 indexed citations
9.
Segarra-Medrano, Alfons, et al.. (2016). Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis. PLoS ONE. 11(9). e0161527–e0161527. 6 indexed citations
11.
Simeón‐Aznar, Carmen Pilar, et al.. (2011). Características clínicas y pronóstico de los pacientes con crisis renal esclerodérmica. Medicina Clínica. 137(10). 431–434. 4 indexed citations
12.
Martínez‐Lostao, Luis, Josep Ordi‐Ros, Eva Balada, et al.. (2007). Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus. 16(7). 483–488. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026